Business World covers Latest Business News. News Business Politics Entertainment Sports Technology Fashion Beauty Health. passions and curiosity of our readers in all of our journalism.

test

Breaking

Post Top Ad

Your Ad Spot

Tuesday, September 29, 2020

ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021

ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021VICTORIA, BC, Sept. 29, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD.


No comments:

Post a Comment

Sponsor

Ad Banner
Your Ad Spot